TransCode Therapeutics, Inc. Announces $8 Million Private Placement
BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: RNAZ), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that it has entered into a ...
TransCode Therapeutics, Inc.: TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company committed to more effectively treating cancer using RNA ...
TransCode Therapeutics Announces Reverse Stock Split
TransCode Therapeutics ( (RNAZ) ) has provided an update.
TransCode Therapeutics Announces Effective Date for 1-for-33 Reverse Stock Split
TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that its ...
manilatimes1d
Sirios Resources Announces Private Placements
SIRIOS RESOURCES SIRIOS INC. (TSX-V: SOI) (the "Corporation") announces its intention to complete a non-brokered private ...
labiotech4d
Seven miRNA-focused companies pioneering new therapies in 2024
Delve into the field of miRNA with 7 promising companies with miRNA-focused candidates in the pipeline, from oncology to ...
Why Transcode Therapeutics (RNAZ) Stock Is Moving
Transcode Therapeutics shares are trading lower by 11% to 34 cents Monday afternoon. The company announced its Board's ...
TransCode Announces 1-for-33 Reverse Stock Split
TransCode Therapeutics, Inc. (RNAZ), a company focused on cancer treatment using RNA therapeutics, said on Monday that its Board has ...
Transcode Therapeutics announces 1-for-33 reverse stock split
Board of Directors has approved a 1-for-33 reverse stock split. The reverse stock split was approved by TransCode’s ...